Burning Rock Biotech Ltd. (BNR)
NASDAQ:BNR
US Market
Holding BNR?
Track your performance easily

Burning Rock Biotech (BNR) Financial Statements

82 Followers

Burning Rock Biotech Financial Overview

Burning Rock Biotech's market cap is currently ―. The company's EPS TTM is $-7.654; its P/E ratio is -0.35; Burning Rock Biotech is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue¥ 121.57M¥ 127.57M---
Gross Profit¥ 78.60M¥ 85.92M---
EBIT¥ -161.14M----
EBITDA¥ -27.74M----
Net Income Common Stockholders¥ -162.21M¥ -174.98M---
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 615.10M¥ 636.29M¥ 0.00¥ 0.00¥ 925.27M
Total Assets¥ 1.04B¥ 1.17B--¥ 1.59B
Total Debt¥ 12.32M¥ 19.09M¥ 0.00¥ 0.00¥ 50.79M
Net Debt¥ -602.77M¥ -617.20M¥ 0.00¥ 0.00¥ -874.48M
Total Liabilities¥ 271.59M¥ 303.75M--¥ 429.13M
Stockholders Equity¥ 768.41M¥ 862.97M¥ 0.00¥ 0.00¥ 1.16B
Cash Flow-
Free Cash Flow¥ -25.32M¥ -47.42M¥ -79.20M¥ -113.14M-
Operating Cash Flow¥ -16.02M¥ -47.42M---
Investing Cash Flow¥ -328.00K¥ -1.99M---
Financing Cash Flow¥ -1.91M¥ -45.89M---
Currency in CNY

Burning Rock Biotech Earnings and Revenue History

Burning Rock Biotech Debt to Assets

Burning Rock Biotech Cash Flow

Burning Rock Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis